Crossmark

Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line

Published Online: 2021-01-18

Published Print: 2021-12

Authors

Umar, Abdullahi Bello

Uzairu, Adamu

Shallangwa, Gideon Adamu

Uba, Sani
License Information

Text and Data Mining valid from 2021-01-18

Version of Record valid from 2021-01-18
More Information

Article History

Received: 4 September 2020

Accepted: 17 December 2020

First Online: 18 January 2021

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current